Table 2.
Patient characteristics of the included studies.
| Study | N total | N intervention (I) | N controls (C) | Age (years) | Gender m/f | Mean follow-up (moths) |
|---|---|---|---|---|---|---|
| McKee et al. 2010 [19] | 30 | 15 | 15 | 44.1 (I) 45.6 (C) |
11/4 (I) 10/5 (C) |
38 (26–60) |
| Gitelis and Brebach 2002 [20] | 6 | 6 | 0 | 50 | 3/3 | 28 (12–84) |
| von Stechow et al. 2005 [21] | 16 | 16 | 0 | ? (38–85) | 13/3 | ? (12–48) |
| Chang et al. 2007 [22] | 65 | 25 | 40 | 39.8 (18–69) | 36/29 | 75 (36–344) |
| Tsai et al. 2004 [23] | 2 | 2 | 0 | 54 (80–28) | 2/0 | 36 |
| von Stechow and Rauschmann 2009 [24] | 12 | 12 | 0 | 59 (39–74) | 8/4 | ? (12–?) |
| Berner et al. 2008 [25] | 1 | 1 | 0 | 49 | 1/0 | 24 |
| Drago et al. 2013 [26] | 27 | 27 | 0 | 44 (20–80) | 18/9 | 17.8 (9–30) |
| Lindfors et al. 2010 [27] | 11 | 11 | 0 | ? (16–84) | 9/2 | 24 (10–38) |
| McAndrew et al. 2013 [28] | 3 | 3 | 0 | 44.7 (26–68) | 2/1 | 17.3 (14–21) |
| Romanò et al. 2014 [29] | 76 | 27 | 49 | 45.2 (19–80) | 49/27 | 21.8 (12–36) |
| Fleiter et al. 2014 [30] | 20 | 20 | 0 | 51.1 (24–79) | 16/4 | ? |
| Ferguson et al. 2014 [31] | 193 | 193 | 0 | 46.1 (16–82) | 150/43 | 44.4 (15.6–81.2) |
| Humm et al. 2014 [32] | 21 | 21 | 0 | 49 (26–88) | 18/3 | 16 (6–25) |
| Franceschini et al. 2012 [33] | 1 | 1 | 0 | 32 | 1/0 | 12 |